Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
The Lancet. Haematology|February 13, 2025
Long-term efficacy and safety of luspatercept for the treatment of anaemia in patients with transfusion-dependent β-thalassaemia (BELIEVE): final results from a phase 3 randomised trialMaria Domenica Cappellini, Vip Viprakasit, Pencho Georgiev, et al.
Experimental Hematology & Oncology|December 20, 2018
The epidemiology and clinical characteristics of myeloproliferative neoplasms in MalaysiaYee Yee Yap, Kian Boon Law, Jameela Sathar, et al.
The New England Journal of Medicine|March 27, 2020
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-ThalassemiaM Domenica Cappellini, Vip Viprakasit, Ali T Taher, et al.
The New England Journal of Medicine|March 13, 2024
Oral Iptacopan Monotherapy in Paroxysmal Nocturnal HemoglobinuriaRégis Peffault de Latour, Alexander Röth, Austin G Kulasekararaj, et al.
The Lancet. Haematology|May 30, 2025
Oral iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria: final 48-week results from the open-label, randomised, phase 3 APPLY-PNH trial in anti-C5-treated patients and the open-label, single-arm, phase 3 APPOINT-PNH trial in patients previously untreated with complement inhibitorsAntonio M Risitano, Austin G Kulasekararaj, Phillip Scheinberg, et al.
Pageof 5